~~<i id='5922DAA6FF'><strike id='5922DAA6FF'><tt id='5922DAA6FF'><pre id='5922DAA6FF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

explore

author：fashion 2025-10-02 22:28:07 - browse：78128

Limor Appelbaum, radiation oncologist and a researcher working on the effort to predict pancreatic cancer for early detection, using AI analysis of vast amounts of electronic health records. -- health coverage from STAT — Suzanne Kreiter/Globe staff

Limor Appelbaum has seen too many patients whose first sign of a fatal illness came too late.

Often it’s yellowed eyes from jaundice, caused by a cancerous tumor on the pancreas that has grown so large it presses against the bile duct system. By this point, little can be done. “All we can really offer them is something that can prolong life by a few months,” and comfort care, said Appelbaum, a staff scientist at Beth Israel Deaconess Medical Center.

Only 11 percent of people diagnosed with pancreatic cancer are alive five years later.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Biogen nominates mother of director’s child to replace him on board

leisure time

hotspot

entertainment

hotspot

leisure time

IllustrationofaBiTE,Amgen'sbispecificantibodiesAmgenIncancerimmunotherapythesedays,technologyisadvan

WSS

Biden administration plans revamp of organ transplant system

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

UCLA team creates talking throat patch for voice disorders

EPA limits use of carcinogenic gas for sterilizing medical devices

Mom launches Girl Scout troop for LGBTQ youth in Texas

Steward Health Care Massachusetts hospitals face fiscal disaster

hotspot

explore

leisure time

Medicare details structure of new drug price negotiation program

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

United colonoscopy coverage change 'may cost lives,' doctors say

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Walensky prepares to leave CDC — and Congress — behind

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Peter Hotez and the public health issue of online harassment

Readout Newsletter: CAR

State Dept. review finds Biden bears some blame for Afghanistan failures

Reanimated hearts work just as well for transplants, study finds

hotspot

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

How to fix the rural physician shortage in the U.S.

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Timeline: Key moments in fight for gay rights

A public health expert passes on football's full body collisions for youths

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

hotspot

entertainment

hotspot

leisure time